Imagerie par Résonance Magnétique, Imagerie multi-échelle, Intelligence artificielle, Atlas cérébral

The IMA-brain team focuses on the development and clinical validation of quantitative neuroimaging biomarkers to improve the diagnoses, treatment decision, prognosis, and ultimately outcomes of patients with brain diseases. The team is organized around three main application axes (Neuro-Vascular, Brain tumors, and Mental disorders), each coordinated by subgroup leaders with internationally recognized expertise. Together, the three axes cover a spectrum of pathological conditions, each with different time scales: acute onset (stroke), rapid or slow progression (Brain tumors), or lifelong evolution (mental disorders). We use state-of-the-art MRI acquisition and image processing techniques as well as advanced data analytics approaches including machine learning and multiscale imaging to achieve these goals. The team members, who share interest in MR biomarkers, have multidisciplinary skills: psychiatrists, neuropathologists, neurosurgeons, neuroradiologists, cognitive neuroscientists, research engineers with skills in physics of MR, micro-structural and fMRI analysis. A synergy between the three clinical axes fosters, in an interdisciplinary context, the sharing of (1) methods for developing imaging biomarkers and (2) theoretical approaches across application domains. 

Adresse :
INSERM U1266, 102-108 rue de la santé, 75014, Paris

Responsable équipe :
Catherine Oppenheim
Nom du Co-responsable équipe :

Nom du Contact administratif :


Site web : Cliquez ici
Mots clés : #Système #nerveux #central #IRM #AVC #tumeur #psychiatrie #Brain #MRI #Stroke #Tumor #Mental #disorders